Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Whitehawk Therapeutics (WHWK) Return on Capital Employed (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Return on Capital Employed for 8 consecutive years, with 0.03% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 108.0% to 0.03% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.03% through Dec 2025, up 108.0% year-over-year, with the annual reading at 0.05% for FY2025, 76.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.03% at Whitehawk Therapeutics, up from 0.66% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.03% in Q4 2025, with the low at 1.11% in Q4 2024.
  • Average Return on Capital Employed over 5 years is 0.6%, with a median of 0.61% recorded in 2023.
  • The sharpest move saw Return on Capital Employed tumbled -107bps in 2022, then skyrocketed 108bps in 2025.
  • Over 5 years, Return on Capital Employed stood at 0.75% in 2021, then surged by 51bps to 0.37% in 2022, then crashed by -78bps to 0.66% in 2023, then tumbled by -69bps to 1.11% in 2024, then skyrocketed by 97bps to 0.03% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.03%, 0.66%, and 0.52% for Q4 2025, Q3 2025, and Q2 2025 respectively.